IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.2979
-0.0082 (-2.68%)
At close: Dec 5, 2025, 4:00 PM EST
0.3000
+0.0021 (0.70%)
After-hours: Dec 5, 2025, 8:00 PM EST
IGC Pharma Employees
IGC Pharma had 70 employees as of March 31, 2025. The number of employees increased by 3 or 4.48% compared to the previous year.
Employees
70
Change (1Y)
3
Growth (1Y)
4.48%
Revenue / Employee
$15,800
Profits / Employee
-$92,086
Market Cap
27.67M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IGC News
- 4 days ago - IGC Pharma Announces Publication of Landmark Caregiver Book on Alzheimer's Disease - Accesswire
- 11 days ago - IGC Pharma Leverages MINT-AD to Identify Socioeconomic Risk Factors Driving Alzheimer's and Aging Trends - Accesswire
- 19 days ago - IGC Pharma Reports Accelerated Q2 Progress and Strengthened Financial Focus: CALMA Trial Passes 50% Enrollment Milestone, Strategic Divestiture Optimizes Capital - Accesswire
- 23 days ago - USPTO Grants IGC Pharma Patent Covering IGC-AD1 for Novel Composition Targeting Alzheimer's Disease and Central Nervous System Disorders - Accesswire
- 26 days ago - IGC Pharma to Host Mid-Year Fiscal 2026 Shareholder Update Call on November 17, 2025 - Accesswire
- 4 weeks ago - IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline - Accesswire
- 6 weeks ago - IGC Pharma Advances to Semi-Finals in the Alzheimer's Insights AI Prize with "AHA: Agentic Harmonization Assistant" - Accesswire
- 7 weeks ago - IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida's Department of Psychiatry and Behavioral Neurosciences - Accesswire